01 آذر 1403
فا EN
logo

Chronic Diseases Research Center

Tehran University of Medical Scienses

 

 

Journal & Year Link Authors Title  
Journal of Health Insurance, 2024, 1, e1 10.34172/jhi.5 Darvishi A., Heshmat R.   Optimizing Health Insurance Capacity for Noncommunicable Diseases in Iran: A Vital Imperative 1
BMC Public Health, (2024) 24:926 https://doi.org/10.1186/s12889-024-18452-7 Darvishi A. , Nikkhah A. , Mahmudimanesh M. , Zargar Balajam N. , Shafiee G. and Heshmat R. Socioeconomic inequalities in type 2 diabetes mellitus: a study based on a population-based survey in Iran 2
CURRENT MEDICAL RESEARCH AND OPINION, Revised 29 February 2024 Accepted 18 March 2024 https://doi.org/10.1080/03007995.2024.2333425 Heshmat R., Darvishi A., Abdi Dezfouli R., Nikkhah A., Radmanesh R. & Moslemi E. A short-term economic evaluation of early insulin therapy compared to oral anti-diabetic drugs in order to reduce the major adverse events in type 2 diabetes patients in Iran 3
Health Economics Review (2024) Published online: 09 November 2023 https://doi.org/10.1186/s13561-023-00463-6 Darvishi A, Daroudi R, Fazaeli AA Cost-utility analysis of Palbociclib + letrozole and Ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model 4
BMC Public Health 23, 819 (2023) https://doi.org/10.1186/s12889-023-15693-w Darvishi A., Shafiee G., Zargar-Balajam N., Rezaei-Hemami M., Ostovar N., Heshmat R Cost-effectiveness analysis of sarcopenia management interventions in Iran 5
Iran J Public Health. 2023;52(2):407-419 https://doi:10.18502/ijph.v52i2.11894 Asadollahi M, Darvishi A, Azimi A, Annabi M, Jafariazar Z, Heshmat R Economic Burden of Multiple Sclerosis Drugs in Iran during 2011-2019 6
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Published online: 28 Aug 2023 https://doi.org/10.1080/14737167.2023.2251689 Daroudi R, Mousavi MT, Shirazikhah M, Alizadeh Zarei M, Hendi HR, Joghataei F, Darvishi A Cost-utility analysis of multiple sclerosis rehabilitation in Iran 7
Expert Review of Pharmacoeconomics & Outcomes Research (2023) http://dx.doi.org/10.1080/14737167.2023.2263167 Darvishi A, AbdiDezfouli R, Fazaeli AA, Daroudi R Is Palbociclib a cost-effective strategy in the second-line treatment of metastatic breast cancer in Iran? 8
BMC Public Health 23, 1393 (2023) https://doi.org/10.1186/s12889-023-16244-z Jasemi, S.V., Zandieh, Z, Zandieh N, Rezaei Hemami M, Darvishi A, Abdollahi Z, Heshmat R Is vitamin D supplementation program in Iranian schools effective in reducing adolescent depressive symptoms? Cost effectiveness study 9
Expert Review of Pharmacoeconomics & Outcomes Research (2023) 10 Apr 2023 https://doi.org/10.1080/14737167.2023.2200938 Darvishi A, Mousavi MT, Abdi Dezfouli R, Shirazikhah M, Alizadeh zarei M, Hendi HR, Joghataei F, Daroudi R Cost-benefit analysis of stroke rehabilitation in Iran 10
Expert Review of Pharmacoeconomics & Outcomes Research (2023) https://doi.org/10.1080/14737167.2023.2263164 Bashari N, Safaei-Lari M, Darvishi A, Daroudi R Cost-Utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran 11
PLoS ONE, 2022; 17(7): e0270642 https://doi.org/10.1371/journal.pone.0270642 Darvishi A; Sadeighipoor P; Darroudi A; Daroudi R. Cost-Utility Analysis of Cryoballoon Ablation versus Radiofrequency Ablation in the Treatment of Paroxysmal Atrial Fibrillation; Case Study: Iran 12
BMC Complementary Medicine and Therapies 2022, 22(1): 1-9 https://doi.org/10.1186/s12906-021-03474-0 Zandieh N, Rezaei Hemami M, Darvishi A, Zarei M, Hasheminejad SM, Abdollahi Z, Heshmat R. Economic evaluation of a national vitamin D supplementation program among Iranian adolescents for the prevention of adulthood type 2 diabetes mellitus 13
Expert Review of Pharmacoeconomics & Outcomes Research 2022, 29 Nov 2022. https://doi.org/10.1080/14737167.2023.2152008 Kosar Hajian, Ramin Abdi Dezfouli, Ali Darvishi, Ramin Radmanesh & Ramin Heshmat Tenecteplase in managing acute ischemic stroke: a long-term cost-utility analysis in Iran 14
jrehab 2022; 23 (3) :412-433 http://rehabilitationj.uswr.ac.ir/article-1-2926-en.html Mousavi MT; Daroudi R; Shirazikhah M; Alizadeh zarei M; Hendi HR; Joghataei F; Darvishi A Economic evaluation of spinal cord injury (SCI) rehabilitation in Iran. Archives of Rehabilitation 15
BMC Health Services Research. 2022 Feb 2;22(1):137 https://doi:10.1186/s12913-022-07551-z Mina Asadollahi; Darvishi A; Azimi AR; Annabi M; Jafariazar Z; Heshmat R Estimation the Medical Cost of Multiple Sclerosis in Iran; 2019-2020 16
Public Health. 2021. Volume 198, September: 340-347.

/https://www.sciencedirect.com/science/

article/abs/pii/S0033350621002882

 Zandieh N, Rezaei Hemami M, Darvishi A, Zarei M, Hasheminejad SM, Abdollahi Z, Heshmat R. The Cost-Effectiveness Analysis of a Nationwide Vitamin D Supplementation Program Among Iranian Adolescents for the Adulthood Cardiovascular Diseases Prevention 17
BMC Public Health. 2021. 21:926. https://doi.org/10.1186/s12889-021-10511-7 Darvishi A; Rezaei Hemami M; Shafiee G*; Daroudi R; Mohseni M; Hosseini Shekarabi F; Heshmat R. Sarcopenia Screening Strategies in Older People: A Cost Effectiveness Analysis in Iran 18

 

 

 

 

دسترسی سریع

لینک‌های مفید

نظرات

All rights of this site belong to the Chronic Diseases Research Center

اسپریت پرتال نیافام
متن مورد نظر خود را جستجو کنید

تغییر رنگ فونت:

رنگ اصلی:

رنگ دوم:

تغییر رنگ پس زمینه:

تغییر اندازه فونت:

فونت نمونه-آفونت نمونه+

تغییر فاصله بین کلمات:

تغییر فایله بین خطوط:

تغییر نوع موس:

تغییر فونت

انتخاب حالت کور رنگی

سرخ کوری سبز کوری آبی کوری سرخ دشوار بینی سبز دشوار بینی آبی دشوار بینی تک رنگ بینی تک رنگ بینی مخروطی
تنظیمات پس زمینه